Navigation Links
Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
Date:10/24/2013

0.6 3.5 (1.9) 3.6 Total other expense, net (8.0) (4.8) (27.3) (23.1) Income before income taxes and equity in (losses)/earnings of equity method investees 332.8 268.6 784.4 847.5 Income taxes (54.3) (41.6) (183.9) (144.6) Equity in (losses)/earnings of equity method investees, net of taxes (0.3) 0.2 0.6 0.5 Net income 278.2 227.2 601.1 703.4

  1. R&D includes intangible asset impairment charges of $19.9 million for the nine months to September 30, 2013 (2012: $27.0 million). SG&A costs include amortization and impairment charges of intangible assets relating to intellectual property rights acquired of $44.4 million for the three months to September 30, 2013 (2012: $50.0 million) and $136.1 million for the nine months to September 30, 2013 (2012: $146.6 million).


Unaudited US GAAP results for the three months and nine months to September 30, 2013
Consolidated Statements of Income (continued)

9 months 9 months 3 months to 3 months to to to September September September 30, September 30, 30, 30, 2013 2012 2013 2012 Earnings per ordinary share - basic Earnings per Ordinary Share - basic 50.7c 40.9c 109.3c 126.6c Earnings per ADS - basic 152.1c 122.7c 327.9c 379.8c Earnings per Ordinary Share - diluted 48.8c 39.6c 106.2c 122.4c Earnings per ADS - diluted 146.4c 118.8c 318.6c 367.2c Weighted average number of shares: Millions Millions Millions Millions Basic 548.4 555.9 549.8 555.5 Diluted 585.7 593.1 587.5 594.0

Unaudited US GAAP results for the three months and nine months to September 30, 2013
Consolidated Statements of Cash Flows

3 months to 9 months to September 30, September 30, 2013 2012 2013 2012 $M $M $M $M CASH FLOWS FROM OPERATING ACTIVITIES: Net income 278.2 227.2 601.1 703.4 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 78.2 79.1 229.4 231.5 Share based compensation 18.8 21.6 55.2
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
6. Shire Changes its NASDAQ Ticker Symbol to SHPG
7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
9. Shire Reaches Agreement in Principle With U.S. Government
10. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
11. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Neurotrope, Inc. (OTCQB: ... conference call to provide an update on Company ... daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or ... cast: www.neurotropebioscience.com , under "Investor Relations"The teleconference replay ... through September 2, 2014 at (888) 203-1112 (U.S. ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
(Date:8/20/2014)... The 6th Annual Arrowhead Personalized ... October 29-30 in San Francisco, CA. This year’s conference ... researchers and clinicians focused on addressing and solving the ... the twelve years since the sequencing of the human ... with pharmacogenetic information in the label and molecular diagnostics ...
(Date:8/20/2014)... 20, 2014 /PRNewswire-iReach/ -- A case study from ... the school,s bioengineering department and the Intel® Internet ... Software Academic Program, UCSD,s research focuses on exploring ... body.  Photo - http://photos.prnewswire.com/prnh/20140819/137540 ... work of Dr. Todd P. Coleman , ...
Breaking Biology Technology:Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 36th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2
... Jan. 2 CryoLife, Inc. (NYSE: CRY ... announced today,that it is scheduled to participate in ... Sir Francis Drake Hotel in Union Square, San,Francisco., ... operating officer and,chief financial officer of CryoLife, Inc., ...
... SAN FRANCISCO, Calif., Jan. 2 Exelixis,Inc. (Nasdaq: ... president and chief executive officer, will present at the ... 10:30 p.m. ET on,Thursday, January 10, 2008., The ... the Event,Calendar page under Investors on the Exelixis website ...
... Jan. 2 The following statement was issued,today by the ... Notice is hereby given that a class action lawsuit was ... of New York on,behalf of all purchasers of the securities ... February 17, 2006 through June 13, 2007,inclusive (the "Class Period")., ...
Cached Biology Technology:Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3
(Date:8/21/2014)... University (ANU) team has successfully replicated one of the ... systems powered by sunlight which could manufacture hydrogen as ... sunlight. It is an exciting prospect to use them ... said Dr Kastoori Hingorani, from the ARC Centre of ... of Biology. , Hydrogen offers potential as a zero-carbon ...
(Date:8/21/2014)... resulting in severe abdominal pain, vomiting and systemic inflammation. ... diagnosed with the disease resulting in 1000 deaths. There ... intravenous fluid and nutritional support. , Dr Jason ... the research, said "The major causes of pancreatitis include ... intake combined with a high fat diet. In fact, ...
(Date:8/20/2014)... study of 158 pregnant teenagers in Rochester, NY, nearly ... consumption of ice, cornstarch, vacuum dust, baby powder and ... study. , Moreover, such teens had significantly lower iron ... nonfood substances. , Pregnant teens, regardless of pica, are ... to iron deficiency and anemia. Low iron in pregnant ...
Breaking Biology News(10 mins):Water and sunlight the formula for sustainable fuel 2Insulin offers new hope for the treatment of acute pancreatitis 2Pica in pregnant teens linked to low iron 2
... facing the world,s marine environments. Yet in the absence of ... plastic litter enter the ocean each year. ... Emmett Center on Climate Change and the Environment and UCLA,s ... impacts of plastic marine litter and offers domestic and international ...
... PARK, Calif. , Oct. 29, 2013 /PRNewswire-iReach/ -- ... buyout capital to emerging healthcare companies, announced today that ... Pharmaceuticals, has joined the Frazier Healthcare team as a ... long and distinguished track record as an entrepreneur, executive, ...
... and clinicians were unsung heroes during the early years (19771983) ... (VTEC). In an article published today in the Canadian ... microbiologist, documents the history of this area of study, ... Canadians to the science of what many people refer to ...
Cached Biology News:UCLA report urges new global policy effort to tackle crisis of plastic litter in oceans 2UCLA report urges new global policy effort to tackle crisis of plastic litter in oceans 3Frazier Healthcare Adds Carol Gallagher to its Life Science Team 2Frazier Healthcare Adds Carol Gallagher to its Life Science Team 3Canadian discoveries pivotal to the science of toxins and illness associated with E. coli 2
... the LVF-HL, LVF-CUVADPT, FHS-LVF, and the CVD-Diffuse ... low-pass Linear Variable Filters to create the ... center wavelength and adjustable bandpass. Each filter ... blocking band (99.8%). These filters -- ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Ms anti-Cyclophilin D...
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: